Literature DB >> 23861318

Spatiotemporal brain dynamics of emotional face processing modulations induced by the serotonin 1A/2A receptor agonist psilocybin.

Fosco Bernasconi1, André Schmidt1, Thomas Pokorny1, Michael Kometer1, Erich Seifritz2, Franz X Vollenweider1.   

Abstract

Emotional face processing is critically modulated by the serotonergic system. For instance, emotional face processing is impaired by acute psilocybin administration, a serotonin (5-HT) 1A and 2A receptor agonist. However, the spatiotemporal brain mechanisms underlying these modulations are poorly understood. Here, we investigated the spatiotemporal brain dynamics underlying psilocybin-induced modulations during emotional face processing. Electrical neuroimaging analyses were applied to visual evoked potentials in response to emotional faces, following psilocybin and placebo administration. Our results indicate a first time period of strength (i.e., Global Field Power) modulation over the 168-189 ms poststimulus interval, induced by psilocybin. A second time period of strength modulation was identified over the 211-242 ms poststimulus interval. Source estimations over these 2 time periods further revealed decreased activity in response to both neutral and fearful faces within limbic areas, including amygdala and parahippocampal gyrus, and the right temporal cortex over the 168-189 ms interval, and reduced activity in response to happy faces within limbic and right temporo-occipital brain areas over the 211-242 ms interval. Our results indicate a selective and temporally dissociable effect of psilocybin on the neuronal correlates of emotional face processing, consistent with a modulation of the top-down control.
© The Author 2013. Published by Oxford University Press. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  5-HT1A/2A receptors; EEG; emotional face processing; psilocybin; source estimation

Mesh:

Substances:

Year:  2013        PMID: 23861318     DOI: 10.1093/cercor/bht178

Source DB:  PubMed          Journal:  Cereb Cortex        ISSN: 1047-3211            Impact factor:   5.357


  15 in total

Review 1.  Molecular Mechanisms of Psilocybin and Implications for the Treatment of Depression.

Authors:  Susan Ling; Felicia Ceban; Leanna M W Lui; Yena Lee; Kayla M Teopiz; Nelson B Rodrigues; Orly Lipsitz; Hartej Gill; Mehala Subramaniapillai; Rodrigo B Mansur; Kangguang Lin; Roger Ho; Joshua D Rosenblat; David Castle; Roger S McIntyre
Journal:  CNS Drugs       Date:  2021-11-17       Impact factor: 5.749

Review 2.  Recent advances in the neuropsychopharmacology of serotonergic hallucinogens.

Authors:  Adam L Halberstadt
Journal:  Behav Brain Res       Date:  2014-07-15       Impact factor: 3.332

3.  Effects of serotonin 2A/1A receptor stimulation on social exclusion processing.

Authors:  Katrin H Preller; Thomas Pokorny; Andreas Hock; Rainer Kraehenmann; Philipp Stämpfli; Erich Seifritz; Milan Scheidegger; Franz X Vollenweider
Journal:  Proc Natl Acad Sci U S A       Date:  2016-04-18       Impact factor: 11.205

4.  Psychedelics, Meditation, and Self-Consciousness.

Authors:  Raphaël Millière; Robin L Carhart-Harris; Leor Roseman; Fynn-Mathis Trautwein; Aviva Berkovich-Ohana
Journal:  Front Psychol       Date:  2018-09-04

Review 5.  Psychedelics.

Authors:  David E Nichols
Journal:  Pharmacol Rev       Date:  2016-04       Impact factor: 25.468

6.  Interaction between valence of empathy and familiarity: is it difficult to empathize with the positive events of a stranger?

Authors:  Yuki Motomura; Akira Takeshita; Yuka Egashira; Takayuki Nishimura; Yeon-Kyu Kim; Shigeki Watanuki
Journal:  J Physiol Anthropol       Date:  2015-03-22       Impact factor: 2.867

Review 7.  Dreams and Psychedelics: Neurophenomenological Comparison and Therapeutic Implications.

Authors:  Rainer Kraehenmann
Journal:  Curr Neuropharmacol       Date:  2017       Impact factor: 7.363

8.  Effect of Psilocybin on Empathy and Moral Decision-Making.

Authors:  Thomas Pokorny; Katrin H Preller; Michael Kometer; Isabel Dziobek; Franz X Vollenweider
Journal:  Int J Neuropsychopharmacol       Date:  2017-09-01       Impact factor: 5.176

Review 9.  Serotonergic hallucinogens and recognition of facial emotion expressions: a systematic review of the literature.

Authors:  Juliana M Rocha; Flávia L Osório; José Alexandre S Crippa; José Carlos Bouso; Giordano N Rossi; Jaime E C Hallak; Rafael G Dos Santos
Journal:  Ther Adv Psychopharmacol       Date:  2019-04-26

Review 10.  Modulation of Social Cognition via Hallucinogens and "Entactogens".

Authors:  Katrin H Preller; Franz X Vollenweider
Journal:  Front Psychiatry       Date:  2019-12-03       Impact factor: 4.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.